Tag: Abbott Vascular
New study to evaluate safety of three-month DAPT with Xience in high bleeding risk patients
A new study, XIENCE S...
ACC 2017: Two-year rate of target lesion failure significantly higher with Absorb
Two-year data from th...
The implications of ABSORB II three-year results for the future of bioresorbable scaffolds
The idea of a fully b...
Combining MitraClip mitral valve repair with left atrial appendage occlusion is safe and feasible
Shingo Kuwata (Univer...
PCRLV 2016: MitraClip may be “safe and feasible” for treating tricuspid regurgitation
A first-in-man study ...
